ADAM17 and renal carcinoma: Moreover, A disintegrin and metalloproteinase domain-containing protein 17 (ADAM17) can be directly targeted by miR-145 [202], which initiates a negative feedback loop involving the ADAM17 substrate TNF-α, which is upregulated and subsequently reduces miR-145 expression in renal carcinoma cell lines [203].